Cargando…

Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study

INTRODUCTION: Over recent years there has been growing evidence of increased risk of mortality associated with antipsychotic use in older people with dementia. Although this concern combined with limited evidence of efficacy has informed guidelines restricting antipsychotic prescription in this popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dennis, Michael, Shine, Laura, John, Ann, Marchant, Amanda, McGregor, Joanna, Lyons, Ronan A., Brophy, Sinead
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447553/
https://www.ncbi.nlm.nih.gov/pubmed/28054240
http://dx.doi.org/10.1007/s40120-016-0060-6
_version_ 1783239366342082560
author Dennis, Michael
Shine, Laura
John, Ann
Marchant, Amanda
McGregor, Joanna
Lyons, Ronan A.
Brophy, Sinead
author_facet Dennis, Michael
Shine, Laura
John, Ann
Marchant, Amanda
McGregor, Joanna
Lyons, Ronan A.
Brophy, Sinead
author_sort Dennis, Michael
collection PubMed
description INTRODUCTION: Over recent years there has been growing evidence of increased risk of mortality associated with antipsychotic use in older people with dementia. Although this concern combined with limited evidence of efficacy has informed guidelines restricting antipsychotic prescription in this population, the use of antipsycotics remains common. Many published studies only report short-term outcomes, are restricted to examining mortality and stroke risk or have other limitations. The aim of this study was to assess adverse outcomes associated with the use of antipsychotics in older people living with dementia in Wales (UK). METHODS: This was a retrospective study of a population-based dementia cohort using the Welsh Secure Anonymised Information Linkage databank. The prior event rate ratio (PERR) was used to estimate the influence of exposure to antipsychotic medication on acute cardiac events, venous thromboembolism, stroke and hip fracture, and adjusted Cox proportional hazard models were used to compare all-cause mortality. RESULTS: A total of 10,339 people aged ≥65 years were identified with newly diagnosed dementia. After excluding those who did not meet the inclusion criteria, 9674 people remained in the main cohort of whom 3735 were exposed to antipsychotic medication. An increased risk of a venous thromboembolic episode [PERR 1.95, 95% confidence interval (CI) 1.83–2.0], stroke (PERR 1.41, 95% CI 1.4–1.46) and hip fracture (PERR 1.62, 95% CI 1.59–1.65) was associated with antipsychotic use. However, there was no long-term increased mortality in people exposed to antipsychotics (adjusted hazard ratio 1.06, 95% CI 0.99–1.13). CONCLUSIONS: The increase in adverse medical events supports guidelines restricting antipsychotic use in this population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40120-016-0060-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5447553
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-54475532017-06-13 Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study Dennis, Michael Shine, Laura John, Ann Marchant, Amanda McGregor, Joanna Lyons, Ronan A. Brophy, Sinead Neurol Ther Original Research INTRODUCTION: Over recent years there has been growing evidence of increased risk of mortality associated with antipsychotic use in older people with dementia. Although this concern combined with limited evidence of efficacy has informed guidelines restricting antipsychotic prescription in this population, the use of antipsycotics remains common. Many published studies only report short-term outcomes, are restricted to examining mortality and stroke risk or have other limitations. The aim of this study was to assess adverse outcomes associated with the use of antipsychotics in older people living with dementia in Wales (UK). METHODS: This was a retrospective study of a population-based dementia cohort using the Welsh Secure Anonymised Information Linkage databank. The prior event rate ratio (PERR) was used to estimate the influence of exposure to antipsychotic medication on acute cardiac events, venous thromboembolism, stroke and hip fracture, and adjusted Cox proportional hazard models were used to compare all-cause mortality. RESULTS: A total of 10,339 people aged ≥65 years were identified with newly diagnosed dementia. After excluding those who did not meet the inclusion criteria, 9674 people remained in the main cohort of whom 3735 were exposed to antipsychotic medication. An increased risk of a venous thromboembolic episode [PERR 1.95, 95% confidence interval (CI) 1.83–2.0], stroke (PERR 1.41, 95% CI 1.4–1.46) and hip fracture (PERR 1.62, 95% CI 1.59–1.65) was associated with antipsychotic use. However, there was no long-term increased mortality in people exposed to antipsychotics (adjusted hazard ratio 1.06, 95% CI 0.99–1.13). CONCLUSIONS: The increase in adverse medical events supports guidelines restricting antipsychotic use in this population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40120-016-0060-6) contains supplementary material, which is available to authorized users. Springer Healthcare 2017-01-04 /pmc/articles/PMC5447553/ /pubmed/28054240 http://dx.doi.org/10.1007/s40120-016-0060-6 Text en © The Author(s) 2017 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Dennis, Michael
Shine, Laura
John, Ann
Marchant, Amanda
McGregor, Joanna
Lyons, Ronan A.
Brophy, Sinead
Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
title Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
title_full Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
title_fullStr Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
title_full_unstemmed Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
title_short Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
title_sort risk of adverse outcomes for older people with dementia prescribed antipsychotic medication: a population based e-cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447553/
https://www.ncbi.nlm.nih.gov/pubmed/28054240
http://dx.doi.org/10.1007/s40120-016-0060-6
work_keys_str_mv AT dennismichael riskofadverseoutcomesforolderpeoplewithdementiaprescribedantipsychoticmedicationapopulationbasedecohortstudy
AT shinelaura riskofadverseoutcomesforolderpeoplewithdementiaprescribedantipsychoticmedicationapopulationbasedecohortstudy
AT johnann riskofadverseoutcomesforolderpeoplewithdementiaprescribedantipsychoticmedicationapopulationbasedecohortstudy
AT marchantamanda riskofadverseoutcomesforolderpeoplewithdementiaprescribedantipsychoticmedicationapopulationbasedecohortstudy
AT mcgregorjoanna riskofadverseoutcomesforolderpeoplewithdementiaprescribedantipsychoticmedicationapopulationbasedecohortstudy
AT lyonsronana riskofadverseoutcomesforolderpeoplewithdementiaprescribedantipsychoticmedicationapopulationbasedecohortstudy
AT brophysinead riskofadverseoutcomesforolderpeoplewithdementiaprescribedantipsychoticmedicationapopulationbasedecohortstudy